India, April 30 -- "Hello! I'm Deepti Chavan and I am an MDR-TB survivor. I know how it feels to hear the words ...
I hope I got your attention with my last post about the Pacific Health Summit and the acute global threat of Multi-Drug Resistant Tuberculosis (MDR-TB). All of the issues around innovation in public ...
A new national cohort study provides important insights into the treatment of multidrug-resistant tuberculosis (MDR-TB). The study shows that long-term disease-free survival rates are significantly ...
A long-term study shows MDR-TB treatment success is underestimated, with most patients remaining relapse-free, highlighting ...
Phase 3 STAND Trial Launches to Advance PaMZ through Final Stage of Testing A new tuberculosis (TB) drug regimen designed to improve options for TB therapy eliminated more bacteria from sputum than ...
FRANKLIN LAKES, N.J., April 13, 2021 /PRNewswire/ — BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that its BD MAXTM Molecular Multi-Drug ...
Tuberculosis (TB) disproportionately affects vulnerable populations including those with limited economic resources, HIV patients, those whose diet is deficient in nutrients and others. Resistant TB ...
Last month I attended the Pacific Health Summit in Seattle. It is a pretty exclusive venue (aspiring to be the “Davos of Health Care”) attended by senior representatives from the world of health care ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results